Filing Details
- Accession Number:
- 0001209191-21-063971
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-11-10 19:07:29
- Reporting Period:
- 2021-11-08
- Accepted Time:
- 2021-11-10 19:07:29
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1653087 | Alector Inc. | ALEC | Biological Products, (No Disgnostic Substances) (2836) | 822933343 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1757770 | Arnon Rosenthal | C/O Alector, Inc. 131 Oyster Point Blvd, Suite 600 South San Francisco CA 94080 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-11-08 | 55,000 | $25.00 | 2,137,875 | No | 4 | S | Indirect | See footnote |
| Common Stock | Disposition | 2021-11-08 | 15,000 | $25.00 | 667,500 | No | 4 | S | Indirect | See footnote |
| Common Stock | Disposition | 2021-11-08 | 15,000 | $25.00 | 667,500 | No | 4 | S | Indirect | See footnote |
| Common Stock | Disposition | 2021-11-08 | 15,000 | $25.00 | 667,500 | No | 4 | S | Indirect | See footnote |
| Common Stock | Disposition | 2021-11-09 | 55,000 | $25.00 | 2,082,875 | No | 4 | S | Indirect | See footnote |
| Common Stock | Disposition | 2021-11-09 | 15,000 | $25.00 | 652,500 | No | 4 | S | Indirect | See footnote |
| Common Stock | Disposition | 2021-11-09 | 15,000 | $25.00 | 652,500 | No | 4 | S | Indirect | See footnote |
| Common Stock | Disposition | 2021-11-09 | 15,000 | $25.00 | 652,500 | No | 4 | S | Indirect | See footnote |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | See footnote |
| No | 4 | S | Indirect | See footnote |
| No | 4 | S | Indirect | See footnote |
| No | 4 | S | Indirect | See footnote |
| No | 4 | S | Indirect | See footnote |
| No | 4 | S | Indirect | See footnote |
| No | 4 | S | Indirect | See footnote |
| No | 4 | S | Indirect | See footnote |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 1,455,226 | Direct |
Footnotes
- The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.
- The reported securities are held directly by The Rosenthal Family Revocable Trust Dated November 4, 1994, as restated on June 9, 1999, for which the Reporting Person serves as trustee.
- The reported securities are held directly by the Adi Rosenthal 2007 Trust dated March 27, 2007, for which the Reporting Person serves as trustee.
- The reported securities are held directly by the Noam Rosenthal 2007 Trust dated March 27, 2007, for which the Reporting Person serves as trustee.
- The reported securities are held directly by the Shani Rosenthal 2007 Trust dated March 27, 2007, for which the Reporting Person serves as trustee.
Billionaire Hedge Funds
